Kuros Biosciences received FDA clearance to market the Kuros Transforaminal Lumbar Interbody Fusion cage. The device is to be used with KUR-113, the company’s Fibrin-PTH product candidate for spinal fusion. Clinical trials of the system will now commence.
The cage is available in a range of sizes and cleared for use in the lumbar spine in combination with autograft and/or allograft.
Kuros Biosciences received FDA clearance to market the Kuros Transforaminal Lumbar Interbody Fusion cage. The device is to be used with KUR-113, the company's Fibrin-PTH product candidate for spinal fusion. Clinical trials of the system will now commence.
The cage is available in a range of sizes and cleared for...
Kuros Biosciences received FDA clearance to market the Kuros Transforaminal Lumbar Interbody Fusion cage. The device is to be used with KUR-113, the company’s Fibrin-PTH product candidate for spinal fusion. Clinical trials of the system will now commence.
The cage is available in a range of sizes and cleared for use in the lumbar spine in combination with autograft and/or allograft.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
